Robert R. Pearson

2.5k total citations
37 papers, 1.8k citations indexed

About

Robert R. Pearson is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Robert R. Pearson has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 10 papers in Cardiology and Cardiovascular Medicine and 6 papers in Epidemiology. Recurrent topics in Robert R. Pearson's work include Lipoproteins and Cardiovascular Health (12 papers), Cardiac Imaging and Diagnostics (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Robert R. Pearson is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Cardiac Imaging and Diagnostics (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Robert R. Pearson collaborates with scholars based in United States, China and Germany. Robert R. Pearson's co-authors include Benjamin D. Horne, Jeffrey L. Anderson, Joseph B. Muhlestein, Tami L. Bair, John F. Carlquist, Troy Madsen, Dale G. Renlund, Heidi T. May, Donald Lappé and Qunyu Li and has published in prestigious journals such as Circulation, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Robert R. Pearson

37 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert R. Pearson United States	22	669	501	346	310	209	37	1.8k
Melissa G. Butler United States	24	242 0.4×	203 0.4×	198 0.6×	230 0.7×	85 0.4×	64	1.7k
Moti Haim Israel	23	302 0.5×	1.0k 2.0×	305 0.9×	138 0.4×	95 0.5×	107	1.7k
Suhnggwon Kim South Korea	31	266 0.4×	259 0.5×	320 0.9×	175 0.6×	238 1.1×	116	2.8k
John J. Orloff United States	28	848 1.3×	227 0.5×	909 2.6×	302 1.0×	192 0.9×	49	5.3k
Kiyoshi Ichihara Japan	33	722 1.1×	154 0.3×	422 1.2×	1000 3.2×	136 0.7×	189	3.5k
Tevfik Ecder Türkiye	30	356 0.5×	330 0.7×	261 0.8×	143 0.5×	100 0.5×	110	3.2k
Yeong Hoon Kim South Korea	22	356 0.5×	188 0.4×	176 0.5×	131 0.4×	52 0.2×	104	2.0k
Fraser Cummings United Kingdom	26	533 0.8×	122 0.2×	742 2.1×	98 0.3×	300 1.4×	108	2.3k
Sergi Mojal Spain	25	505 0.8×	230 0.5×	262 0.8×	62 0.2×	160 0.8×	81	1.8k
Cheng‐Hsu Chen Taiwan	23	474 0.7×	95 0.2×	384 1.1×	157 0.5×	98 0.5×	177	2.3k

Countries citing papers authored by Robert R. Pearson

Since Specialization

Citations

This map shows the geographic impact of Robert R. Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert R. Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert R. Pearson more than expected).

Fields of papers citing papers by Robert R. Pearson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert R. Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert R. Pearson. The network helps show where Robert R. Pearson may publish in the future.

Co-authorship network of co-authors of Robert R. Pearson

This figure shows the co-authorship network connecting the top 25 collaborators of Robert R. Pearson. A scholar is included among the top collaborators of Robert R. Pearson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert R. Pearson. Robert R. Pearson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horne, Benjamin D., Heidi T. May, Joseph B. Muhlestein, et al.. (2009). Exceptional Mortality Prediction by Risk Scores from Common Laboratory Tests. The American Journal of Medicine. 122(6). 550–558. 84 indexed citations

May, Heidi T., Benjamin D. Horne, Brianna S. Ronnow, et al.. (2009). Superior predictive ability for death of a basic metabolic profile risk score. American Heart Journal. 157(5). 946–954. 7 indexed citations

Madsen, Troy, Robert R. Pearson, Joseph B Muhlestein, et al.. (2009). Risk of Nephropathy Is Not Increased by the Administration of Larger Volume of Contrast During Coronary Angiography. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 8(4). 167–171. 7 indexed citations

Horne, Benjamin D., Heidi T. May, Jeffrey L. Anderson, et al.. (2008). Usefulness of Routine Periodic Fasting to Lower Risk of Coronary Artery Disease in Patients Undergoing Coronary Angiography. The American Journal of Cardiology. 102(7). 814–819.e1. 78 indexed citations

Rondina, Matthew T., Jason M. Lappé, John F. Carlquist, et al.. (2007). Soluble CD40 Ligand as a Predictor of Coronary Artery Disease and Long-Term Clinical Outcomes in Stable Patients Undergoing Coronary Angiography. Cardiology. 109(3). 196–201. 22 indexed citations

Muhlestein, Joseph B., Heidi T. May, Benjamin D. Horne, et al.. (2006). The Reduction of Inflammatory Biomarkers by Statin, Fibrate, and Combination Therapy Among Diabetic Patients With Mixed Dyslipidemia. Journal of the American College of Cardiology. 48(2). 396–401. 110 indexed citations

Meredith, Kent G., Benjamin D. Horne, Robert R. Pearson, et al.. (2006). Comparison of Effects of High (80 mg) Versus Low (20 mg) Dose of Simvastatin on C-Reactive Protein and Lipoproteins in Patients With Angiographic Evidence of Coronary Arterial Narrowing. The American Journal of Cardiology. 99(2). 149–153. 11 indexed citations

May, Heidi T., Benjamin D. Horne, Jeffrey L. Anderson, et al.. (2006). Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death. American Heart Journal. 152(5). 997–1003. 42 indexed citations

Muhlestein, Joseph B., Jeffrey L. Anderson, Tami L. Bair, et al.. (2005). Improved long-term survival associated with stent deployment during percutaneous coronary interventions: Results from a registry of 3399 patients. American Heart Journal. 150(1). 182–187. 1 indexed citations

10.

Anderson, Jeffrey L., Joseph B Muhlestein, Tami L. Bair, et al.. (2005). Do Statins Increase the Risk of Idiopathic Polyneuropathy?. The American Journal of Cardiology. 95(9). 1097–1099. 20 indexed citations

11.

Madsen, Troy, Joseph B. Muhlestein, John F. Carlquist, et al.. (2005). Serum Uric Acid Independently Predicts Mortality in Patients with Significant, Angiographically Defined Coronary Disease. American Journal of Nephrology. 25(1). 45–49. 56 indexed citations

12.

Horne, Benjamin D., Jeffrey L. Anderson, John F. Carlquist, et al.. (2005). Generating Genetic Risk Scores from Intermediate Phenotypes for Use in Association Studies of Clinically Significant Endpoints. Annals of Human Genetics. 69(2). 176–186. 47 indexed citations

13.

Lavasani, Farangis, Joseph B Muhlestein, Robert R. Pearson, et al.. (2004). 810-5 Use of either metformin or thiazolidinedione is associated with improved survival among patients with type 2 diabetes from a registry of 16,203 diabetic patients. Journal of the American College of Cardiology. 43(5). A474–A474. 3 indexed citations

14.

Anderson, Jeffrey L., Benjamin D. Horne, Sandra P. Reyna, et al.. (2004). Which Features of the Metabolic Syndrome Predict the Prevalence and Clinical Outcomes of Angiographic Coronary Artery Disease?. Cardiology. 101(4). 185–193. 56 indexed citations

15.

Sorensen, Sherman G., Peter J. Casterella, Joseph B Muhlestein, et al.. (2004). 1019-206 Reduced adverse event rates after transcatheter closure of patent foramen ovale when using the amplatzer-PFO™ compared to the CardioSeal™ device. Journal of the American College of Cardiology. 43(5). A377–A377. 2 indexed citations

16.

Muhlestein, Joseph B., Jeffrey L. Anderson, Benjamin D. Horne, et al.. (2004). Early effects of statins in patients with coronary artery disease and high C-reactive protein. The American Journal of Cardiology. 94(9). 1107–1112. 22 indexed citations

17.

Muhlestein, Joseph B., Chloe A. Allen Maycock, John F. Carlquist, et al.. (2002). Inadequate prediction of death by the framingham risk model for patients with existing, angiographically- defined coronary artery disease. Journal of the American College of Cardiology. 39. 441–441. 2 indexed citations

18.

Pearson, Robert R., Benjamin D. Horne, Chloe A. Allen Maycock, et al.. (2002). An institutional discharge medication program reduces future cardiovascular readmissions and mortality: an analysis of 43,841 patients with coronary artery disease. Journal of the American College of Cardiology. 39. 452–452. 6 indexed citations

19.

Muhlestein, Joseph B, Benjamin D. Horne, Tami L. Bair, et al.. (2001). Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. The American Journal of Cardiology. 87(3). 257–261. 128 indexed citations

20.

Uhlenbruck, G., et al.. (1979). Different tridacnins in different tridacnid clams: A comparative study. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 63(1). 125–129. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact